Related Experiment Video
Updated: Aug 15, 2025

Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis
Published on: December 15, 2023
Perforated duodenal ulcer secondary to deferasirox use in a child successfully managed with laparoscopic drainage: A
Abdullah Alshehri1, Tuqa Adil Alsinan2,3
1Department of Surgery, College of Medicine, King Saud University, Riyadh 12372, Saudi Arabia. abalshehri@ksu.edu.sa.
Insights
A perforated duodenal ulcer occurred in a 3-year-old treated with deferasirox for beta thalassemia major. Laparoscopic surgery was successful, highlighting the need for vigilance with this iron chelator.
Area of Science:
- Pediatric Gastroenterology
- Hematology
- Surgical Case Reports
Background:
- Perforated gastroduodenal ulcers are rare in children.
- Deferasirox, an iron chelating agent, is a potential cause of gastroduodenal ulcers.
- Beta-thalassemia major treatment often involves iron chelation therapy.
Observation:
- A 3-year-old boy with beta-thalassemia major developed an acute abdomen.
- Diagnostic workup revealed a perforated duodenal ulcer.
- Laparoscopic exploration confirmed the diagnosis.
Findings:
- The perforated duodenal ulcer was successfully managed with laparoscopic washout and drainage.
- This case highlights a rare but serious gastrointestinal complication associated with deferasirox.
- Minimally invasive surgery proved effective in this pediatric case.
Implications:
- Early recognition and prevention of gastrointestinal issues are critical for children on deferasirox.
- Laparoscopic surgery is a safe and feasible option for selected pediatric patients with perforated duodenal ulcers.
- This case underscores the importance of considering medication side effects in pediatric emergencies.
Background:
A perforated gastroduodenal ulcer is rarely observed in children. Certain medications have been reported to cause ulcerations. Deferasirox, an iron chelating agent, has been previously reported to be associated with the development of gastroduodenal ulcers.
Case Summary:
We report a case of a 3-year-old boy who was diagnosed with beta thalassemia major and treated with deferasirox. He presented to the emergency department with an acute abdomen. A perforated duodenal ulcer was suspected after X-ray imaging and laparoscopic exploration. It was successfully managed with laparoscopic washout and drainage.
Conclusion:
Due to the rarity and severity of this case, it is a reminder that prevention and early recognition of gastrointestinal complications in patients receiving deferasirox are crucial. Minimally invasive laparoscopic surgery is both safe and feasible to treat perforated duodenal ulcers in selected patients.
More Related Videos
05:36Laparoscopic Common Bile Duct Exploration Followed by Primary Suture Using a Modified Bile Duct Incision
Published on: May 2, 2025
03:34Laparoscopic Duodenum-Preserving Pancreatic Head Resection via Inferior Infracolic Approach: A Surgical Approach for Benign Lesions
Published on: February 9, 2024
Related Concept Videos
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Endoscopic Procedures V: ERCP
Patient...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: